Search for: "TEVA USA, INC." Results 161 - 180 of 646
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jun 2018, 7:03 am by Dennis Crouch
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
21 Jun 2018, 4:00 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
20 Jun 2018, 5:00 pm by John Elwood
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
18 Jun 2018, 9:15 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
7 Jun 2018, 4:59 pm by Patent Docs
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
11 Apr 2018, 7:17 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]